Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation

Introduction Early and accurate SLE diagnosis is critical to identify and treat inflammatory organ manifestations before irreversible organ damage occurs. Conventional serological tests (anti-double-stranded DNA (anti-dsDNA), anti-Smith) and complement biomarkers (C3/C4) lack sensitivity in early di...

Descripció completa

Dades bibliogràfiques

Autors principals:	Daniel J Wallace, Michelle A Petri, Michael Mahler, Jennifer L Rogers, Tyler O’Malley, Andrew Concoff, Vasileios C Kyttaris, Howard Busch, Rodney Daniel, Sepehr Taghavi, Touba Warsi, Christine Schleif, Cynthia Alvarez, Brittany D Partain
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2026-05-01
Col·lecció:	Lupus Science and Medicine
Accés en línia:	https://lupus.bmj.com/content/13/1/e002002.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!